Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy

by Loisa Drozdoff, Evelyn Klein, Marion Kiechle, Daniela Paepke
Published 2018-09-01

Evaluation of an Expert Guided Integrative Therapy Concept in Patients With Breast or Gynecological Cancer During Systemic Therapy

by Georg Schmidt, Sofia Mathes, Evelyn Klein, Marion Kiechle, Daniela Paepke
Published 2020-08-01

Demand for integrative medicine among women in pregnancy and childbed: a German survey on patients’ needs

by Nikolas Schürger, Evelyn Klein, Alexander Hapfelmeier, Marion Kiechle, Daniela Paepke
Published 2018-06-01

Pregnancy following Unilateral Immediate Breast Reconstruction with Titanized Polypropylene Mesh (TiLOOP(R) Bra) without Compromising the Result

by Elke Nolte, PhD, Evelyn Klein, MD, Stefan Paepke, MD
Published 2018-09-01

Potential Interactions of Biologically Based Complementary Medicine in Gynecological Oncology

by Loisa Drozdoff, Evelyn Klein, Matthias Kalder, Christine Brambs, Marion Kiechle, Daniela Paepke
Published 2019-05-01

Risk stratification in luminal-type breast cancer: Comparison of Ki-67 with EndoPredict test results

by Aurelia Noske, Sophie-Isabelle Anders, Johannes Ettl, Alexander Hapfelmeier, Katja Steiger, Katja Specht, Wilko Weichert, Marion Kiechle, Evelyn Klein
Published 2020-02-01

Decision impact and feasibility of different ASCO-recommended biomarkers in early breast cancer: Prospective comparison of molecular marker EndoPredict and protein marker uPA/PAI-1...

by Johannes Ettl, Evelyn Klein, Alexander Hapfelmeier, Kirsten Grosse Lackmann, Stefan Paepke, Christoph Petry, Katja Specht, Laura Wolff, Heinz Höfler, Marion Kiechle
Published 2017-01-01

Influence of the sFlt-1/PlGF Ratio on Clinical Decision-Making in Women with Suspected Preeclampsia.

by Evelyn Klein, Dietmar Schlembach, Angela Ramoni, Elena Langer, Franz Bahlmann, Sabine Grill, Helene Schaffenrath, Reinhard van der Does, Diethelm Messinger, Wilma D J Verhagen-Kamerbeek, Manfred Reim, Martin Hund, Holger Stepan
Published 2016-01-01

Corrigendum to “Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, H...

by Andreas Schneeweiss, Johannes Ettl, Diana Lüftner, Matthias W. Beckmann, Erik Belleville, Peter A. Fasching, Tanja N. Fehm, Matthias Geberth, Lothar Häberle, Peyman Hadji, Andreas D. Hartkopf, Carsten Hielscher, Jens Huober, Eugen Ruckhäberle, Wolfgang Janni, Hans Christian Kolberg, Christian M. Kurbacher, Evelyn Klein, Michael P. Lux, Volkmar Müller, Naiba Nabieva, Friedrich Overkamp, Hans Tesch, Elena Laakmann, Florin-Andrei Taran, Julia Seitz, Christoph Thomssen, Michael Untch, Pauline Wimberger, Rachel Wuerstlein, Bernhard Volz, Diethelm Wallwiener, Markus Wallwiener, Sara Y. Brucker
Published 2021-02-01

Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative bre...

by Andreas Schneeweiss, Johannes Ettl, Diana Lüftner, Matthias W. Beckmann, Erik Belleville, Peter A. Fasching, Tanja N. Fehm, Matthias Geberth, Lothar Häberle, Peyman Hadji, Andreas D. Hartkopf, Carsten Hielscher, Jens Huober, Eugen Ruckhäberle, Wolfgang Janni, Hans Christian Kolberg, Christian M. Kurbacher, Evelyn Klein, Michael P. Lux, Volkmar Müller, Naiba Nabieva, Friedrich Overkamp, Hans Tesch, Elena Laakmann, Florin-Andrei Taran, Julia Seitz, Christoph Thomssen, Michael Untch, Pauline Wimberger, Rachel Wuerstlein, Bernhard Volz, Diethelm Wallwiener, Markus Wallwiener, Sara Y. Brucker
Published 2020-12-01